GlassScriptPhysician profile
William H Sher
NPI 1770564296
$1,368.45
in general payments reported to CMS, 2019-2025
22 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $119 · 2021: $79.58 · 2023: $440 · 2024: $316 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $422.80 | 2023-2025 | Inspire |
| Stryker Corporation | $165.46 | 2019-2021 | |
| Glaxosmithkline, LLC. | $131.95 | 2023-2025 | Nucala |
| Pfizer INC. | $68.98 | 2024-2025 | |
| Zoll Respicardia, INC. | $68.91 | 2024 | Remede System |
| Takeda Pharmaceuticals U.S.A., INC. | $45.92 | 2024-2025 | Cuvitru |
| Harmony Biosciences LLC | $43.99 | 2020 | |
| Optinose US, INC. | $38.60 | 2019 | |
| Acclarent, INC | $38.53 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.45 | 2019-2020 | |
| Medtronic, INC. | $35.31 | 2023 | Sinuva, Propel |
| Csl Behring | $31.22 | 2023-2025 | Hizentra |
| Genentech USA, INC. | $30.78 | 2025 | Xolair |
| Genzyme Corporation | $29.61 | 2023 | |
| Merck Sharp & Dohme LLC | $29.39 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $29.38 | 2019 | |
| Integra Lifesciences Corporation | $28.51 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Arbor Pharmaceuticals, INC. | $22.31 | 2019 | |
| Kaleo, INC. | $19.66 | 2024 | Auvi-Q |
| Acelrx Pharmaceuticals, INC. | $19.41 | 2020 | |
| Hikma Pharmaceuticals USA | $19.19 | 2024 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.